CMFT

Inventus Mining Completes Flow-Through Private Placement to Fund Critical Mineral Exploration at its Sudbury 2.0 Project

Retrieved on: 
Friday, May 5, 2023

TORONTO, May 05, 2023 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSX VENTURE: IVS) (“Inventus” or the “Company”) is pleased to report that it has closed a non-brokered private placement of 3,157,895 critical mineral flow-through units (“CMFT Units”), which were sold at $0.095 per Unit for gross proceeds of $300,000 (the “Offering”). Each Unit consists of one common share issued as a “flow-through share” within the meaning of the Income Tax Act (Canada) and one half of a regular common share purchase warrant. Each whole common share purchase warrant entitles the holder to acquire one Common Share for $0.15 for a period of three years after the closing of the Offering.

Key Points: 
  • TORONTO, May 05, 2023 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSX VENTURE: IVS) (“Inventus” or the “Company”) is pleased to report that it has closed a non-brokered private placement of 3,157,895 critical mineral flow-through units (“CMFT Units”), which were sold at $0.095 per Unit for gross proceeds of $300,000 (the “Offering”).
  • Each Unit consists of one common share issued as a “flow-through share” within the meaning of the Income Tax Act (Canada) and one half of a regular common share purchase warrant.
  • Each whole common share purchase warrant entitles the holder to acquire one Common Share for $0.15 for a period of three years after the closing of the Offering.
  • The Company intends to us the proceeds of the Offering to fund exploration at its Sudbury 2.0 Project, including an induced polarization (IP) survey and diamond drilling at the Dorland cobalt prospect.

CIM Real Estate Finance Trust, Inc. to Sell 185 Properties for $894 Million

Retrieved on: 
Friday, December 30, 2022

CIM Real Estate Finance Trust, Inc. (“CMFT”), a leading commercial credit-focused real estate investment trust (REIT), announced today that it has entered into an agreement to sell 185 non-core, net lease properties to Realty Income Corporation (NYSE: O) for $894 million.

Key Points: 
  • CIM Real Estate Finance Trust, Inc. (“CMFT”), a leading commercial credit-focused real estate investment trust (REIT), announced today that it has entered into an agreement to sell 185 non-core, net lease properties to Realty Income Corporation (NYSE: O) for $894 million.
  • Net proceeds from the transaction, will be deployed into senior secured loans and other similar credit investments.
  • The remaining net lease portfolio is primarily financed with a long-term, fixed rate asset-backed securitization.
  • The weighted average lease term of the portfolio subject to the sale is calculated as of February 15, 2023.

CIM Real Estate Finance Trust, Inc. Increases Fourth Quarter Dividends by 11%

Retrieved on: 
Monday, October 17, 2022

This increase, of 11% quarter over quarter, will be reflected in shareholders monthly dividend starting with the October dividend, payable on November 1, 2022.

Key Points: 
  • This increase, of 11% quarter over quarter, will be reflected in shareholders monthly dividend starting with the October dividend, payable on November 1, 2022.
  • As a leading commercial credit-focused real estate investment trust (REIT), CIM believes CMFT is structured to take advantage of market dislocation and opportunities in the current increasing interest rate environment.
  • The rate of future dividends, if any, will be determined by CMFTs board of directors, in its sole discretion.
  • CIM is a community-focused real estate and infrastructure owner, operator, lender and developer.

NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode

Retrieved on: 
Wednesday, August 3, 2022

EDEN PRAIRIE, Minn., Aug. 3, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that the Company entered into an amendment to its Exclusive Development and Distribution Agreement with Zimmer Biomet, Inc. ("Zimmer") that will provide the Company with a $3.5 million accelerated payment within 10 business days which relates to certain milestone payments.  In addition, Zimmer Biomet will receive a Warrant to purchase 350,000 shares of the Company's common stock, with an exercise price of $3.00 per share.

Key Points: 
  • In addition, Zimmer Biomet will receive a Warrant to purchase 350,000 shares of the Company's common stock, with an exercise price of $3.00 per share.
  • Dave Rosa, Chief Executive Officer of NeuroOne, states, "I want to thank Zimmer for all their support to date and their confidence in our business, technology and future endeavors.
  • Under the Exclusive Development and Distribution Agreement signed by both parties in July 2020, Zimmer Biomet has exclusive global distribution rights to distribute the Company's Cortical and sEEG diagnostic electrode technology.
  • Forwardlooking statements may include statements regarding the future of NeuroOne's partnership with Zimmer, NeuroOne's receipt of the $3.5 million payment, and NeuroOne's need for short-term financing.

Inventus Mining: Critical Mineral Flow-Through Private Placement and Unit Offering

Retrieved on: 
Wednesday, June 29, 2022

TORONTO, June 29, 2022 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSX VENTURE: IVS) (“Inventus” or the “Company”) is pleased to announce a non-brokered private placement for up to 3,500,000 critical mineral(1) flow-through units of the Company (each, a “CMFT Unit”) at a price of $0.15 per CMFT Unit and additionally up to 4,500,000 units of the Company (each, a “Unit”) at a price of $0.105 per Unit, for total gross proceed of up to $997,500 (the “Offering”).

Key Points: 
  • Each Unit will consist of one (1) common share of the Company and one-half (0.5) of a share purchase warrant.
  • Each broker warrant will be exercisable into a Unit at a price of $0.105 per Unit for a period of one year.
  • Inventus is a mineral exploration and development company focused on the world-class mining district of Sudbury, Ontario.
  • Our principal assets are a 100% interest in the Pardo Paleoplacer Gold Project and the Sudbury 2.0 Critical Mineral Project located northeast of Sudbury.

Biocomposites signs agreement with Zimmer Biomet to distribute new genex Bone Graft Substitute

Retrieved on: 
Tuesday, March 22, 2022

genex Bone Graft Substitute is a biphasic composite of exceptional purity that is specifically formulated tobalance osteoconductive scaffold strength and persistence in the body to enable the optimal remodelling of bone architecture1.

Key Points: 
  • genex Bone Graft Substitute is a biphasic composite of exceptional purity that is specifically formulated tobalance osteoconductive scaffold strength and persistence in the body to enable the optimal remodelling of bone architecture1.
  • genex Bone Graft Substitute's 50:50 biphasic composition of calcium sulfate and -tricalcium phosphate is not the only performance factor.
  • Michael Harris, Chief Executive Officer of Biocomposites, commented: "I am delighted we are partnering with Zimmer Biomet to deliver our new genex Bone Graft Substitute product to the U.S. market.
  • Bone healing response to a synthetic calcium sulfate/-tricalcium phosphate graft material in a sheep vertebral body defect model.

Biocomposites signs agreement with Zimmer Biomet to distribute new genex Bone Graft Substitute

Retrieved on: 
Tuesday, March 22, 2022

KEELE, England, March 22, 2022 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, today announces that it has entered into a multi-year agreement with Zimmer Biomet (NYSE and SIX: ZBH), a global medical technology leader, to exclusively distribute genex Bone Graft Substitute with its new mixing system and delivery options in the U.S. orthopaedic market.

Key Points: 
  • - genex Bone Graft Substitute upgraded with a new closed-mixing system and a comprehensive set of delivery options for U.S. market
    - Zimmer Biomet will exclusively distribute genex Bone Graft Substitute in the U.S.
    KEELE, England, March 22, 2022 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, today announces that it has entered into a multi-year agreement with Zimmer Biomet (NYSE and SIX: ZBH), a global medical technology leader, to exclusively distribute genex Bone Graft Substitute with its new mixing system and delivery options in the U.S. orthopaedic market.
  • genex Bone Graft Substitute is a biphasic composite of exceptional purity that is specifically formulated tobalance osteoconductive scaffold strength and persistence in the body to enable the optimal remodelling of bone architecture1.
  • genex Bone Graft Substitute's 50:50 biphasic composition of calcium sulfate and -tricalcium phosphate is not the only performance factor.
  • Michael Harris, Chief Executive Officer of Biocomposites, commented: "I am delighted we are partnering with Zimmer Biomet to deliver our new genex Bone Graft Substitute product to the U.S. market.

CIM Real Estate Finance Trust, Inc. to Sell Non-Core, Multi-Tenant Retail Properties for More Than $1.32 Billion

Retrieved on: 
Monday, December 20, 2021

The 81 properties included in the agreement have a weighted average lease term (WALT) of 5.0 years compared with CMFTs remaining portfolio of 437 credit lease properties with a WALT of 10.8 years.

Key Points: 
  • The 81 properties included in the agreement have a weighted average lease term (WALT) of 5.0 years compared with CMFTs remaining portfolio of 437 credit lease properties with a WALT of 10.8 years.
  • Additionally, CMFTs senior secured loan portfolio totaled $1.6 billion as of September 30, 2021.
  • CMFT is a public non-traded corporation that has elected to be taxed and currently qualifies as a REIT.
  • CIM is a community-focused real estate and infrastructure owner, operator, lender and developer.

CIM Real Estate Finance Trust, Inc. Announces Completion of Merger with CIM Income NAV, Inc.

Retrieved on: 
Thursday, December 16, 2021

CIM Real Estate Finance Trust, Inc. (CMFT) announced today it has acquired CIM Income NAV, Inc. (INAV) in a stock-for-stock, tax-free merger transaction pursuant to the definitive agreement executed in September 2021.

Key Points: 
  • CIM Real Estate Finance Trust, Inc. (CMFT) announced today it has acquired CIM Income NAV, Inc. (INAV) in a stock-for-stock, tax-free merger transaction pursuant to the definitive agreement executed in September 2021.
  • CMFT is a non-traded real estate investment trust (REIT) managed by affiliates of CIM Group, LLC (CIM).
  • About CIM Real Estate Finance Trust, Inc.
    CMFT is a public non-traded corporation that has elected to be taxed and currently qualifies as a REIT.
  • CMFT holds investments in net lease and multi-tenant retail assets as well as real estate loans and other credit investments.

CIM Real Estate Finance Trust, Inc. Announces Merger Agreement with CIM Income NAV, Inc.

Retrieved on: 
Thursday, September 23, 2021

CIM Real Estate Finance Trust, Inc. (CMFT) announced today it has entered into a definitive merger agreement to acquire CIM Income NAV, Inc. (INAV) in a stock-for-stock, tax-free merger transaction.

Key Points: 
  • CIM Real Estate Finance Trust, Inc. (CMFT) announced today it has entered into a definitive merger agreement to acquire CIM Income NAV, Inc. (INAV) in a stock-for-stock, tax-free merger transaction.
  • The merger agreement was negotiated on behalf of CMFT and INAV by their special committees composed exclusively of disinterested independent directors.
  • Each respective Board of Directors subsequently unanimously approved the entry by its REIT into the merger agreement.
  • About CIM Real Estate Finance Trust, Inc.
    CMFT is a public non-traded corporation that has elected to be taxed and currently qualifies as a REIT.